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ABSTRACT
Objective: This study aims in constructing a three-dimensional modeled protein structure of potential drug targets in Mycobacterium tuberculosis 
bacteria.
Methods: The protein models were constructed using SWISS-Model online tool. The constructed protein models were submitted in online database 
called Protein Model Database (PMDB) for public access to the structures.
Results: A total of 100 protein sequences of M. tuberculosis were retrieved from UniProt database and were subjected for sequence similarity search 
and homology model construction. The constructed models were subjected for Ramachandran plot analysis to validate the quality of the structures. A 
total of 69 structures were considered to be of significant quality and were submitted to the online database PMDB.
Conclusion: These predicted structures would help greatly in identification and drug design to various strains of M. tuberculosis that are sensitive 
and resistant to different antibiotics. This would greatly help in drug development and personalized drug treatment against different strains of the 
pathogen. This database would significantly support the structure-based computational drug design applications toward personalized medicine in 
regard to differences in the various strains of the pathogen.
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INTRODUCTION
Pharmaceutical industries are greatly depend on structure-based 
computer-aided drug design (SCADD) for manufacturing drugs to 
treat diseases. It uses three-dimensional (3D) structures of proteins 
and protein models, to design a drug specific to the target protein. 
The 3D structures of proteins are usually constructed by analytical 
techniques such as X-ray crystallography and nuclear magnetic 
resonance. However, these techniques were too costly to sustain and 
are time consuming. To tackle these problems, homology modeling 
aims to develop 3D models of proteins based on similarities in other 
protein sequences for which crystallographic structure is available, 
belonging to a different organism. This concept of homology modeling 
was employed in this study, using Swiss-Model tool to construct 
3D structures of known drug target proteins [1-3]. This process of 
homology model uses computational algorithms to compare, match, 
analytically predict the 3D coordinates of amino acid sequences, based 
on pre-existing protein structures that share a significant similarity at 
sequence level [2,4-6].
Mycobacterium tuberculosis causes a disease called tuberculosis [7-10]. 
A recent surge in cases involving strains of this bacterium that is 
resistant to existing antibiotic treatments demands further search 
for new drugs to combat the disease [9-11]. Tuberculosis claims 
over 1.3 million lives a year and many survivors continue to suffer 
through residual organ damage [12]. An established fact is that 
nearly a third of the world population are asymptomatic carriers of 
this bacterium [12]. Epidemiologically, this disease is not an endemic 
disease, however, there is a greater incidence of the disease in tropical 
and subtropical regions such as Africa and parts of Asia. This disease is 
primarily of the respiratory system of humans. Complications of other 
organ systems are also very likely in rare cases of the disease [13]. 
The first strains of this bacterium were known to affect cattle [14], 
however, in early 16th century, it was found that the same bacterium 
had switched hosts and had begun to affect humans with the same 
disease [8].
The bacterium is classified under the family of Mycobacteriaceae and the 
fourth international spoligotyping database has described over 39,000 
different strains of disease-causing bacteria [11,15]. However, diagnosis 
of the disease is reliant on primitive acid-fast staining procedures [16]. 
As a possible application of our database of 3D modeled proteins, there 
is a scope for the use of 3D modeled proteins to accurately diagnose the 
strain causing disease in a particular patient, enabling a personalized 
drug administration [17]. The method has shown promising outcomes 
in the diagnosis of certain inheritable diseases by the study of the 
effect of point mutations in 3D modeled proteins. It is found that this 
bacterium expresses pathogenicity primarily though proteins, which 
with an accurate database of these proteins can speed up diagnosis [14]. 
Another application is that our protein model database (PMDB) aids 
further research and drug development through SCADD.
METHODS
NCBI bibliographic database
The current status of research in the field of protein modeling 
particularly regarding this species of M. tuberculosis was analyzed 
using NCBI database. The NCBI database (https://www.ncbi.nlm.nih.
gov) is a tool that offers a brief understanding of literature and scientific 
experimentation. This lets us ascertain an appropriate procedure for 
this study. A search query of the bacterium yielded all that needed to 
know [1,3,18].
Sequence retrieval
The UniProt Knowledgebase also known as the Universal Protein 
Knowledgebase (https://www.uniprot.org) is a database that contains 
non-redundant protein sequences for many organisms. Protein 
sequences of the various proteins of the bacterium M. tuberculosis were 
© 2020 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2020.v13i11.39242
Research Article
83
Asian J Pharm Clin Res, Vol 13, Issue 11, 2020, 82-85
 Rao et al.
retrieved from this database. It contains amino acid sequences of the 
protein which are available as a .fasta file and it is stored for further 
study. The search query in the database consisted of the name of the 
bacterium without additional parameters [1,2,19].
Sequence alignment
Online server based tool called pBLAST or Protein Basic Local Alignment 
Search Tool (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins) 
was used for analyzing the retrieved sequences by comparing it to a 
pre-existing repository of amino acid sequence data in the Protein Data 
Bank. This gives results in the form a percentage similarity. The percent 
match was recorded. However, those proteins with a low percent match 
were discarded from the study [1,20].
Structure prediction
The amino acid sequence data from the UniProt website in the .fasta 
file format were subjected to protein modeling. This process constructs 
the 3D models of the proteins based on the sequence data and an 
algorithm that compares it to other pre-existing modeled proteins 
through the concept of homology modeling. For this SWISS-Model 
(https://swissmodel.expasy.org) was used. The process generates 
multiple models for each submitted protein which are stored as .pdb 
file [2,4-6,21].
Model analysis
The SWISS-Model also offers a tool called MolProbity used for 
qualitative analysis of the protein structure [1]. Ramachandran 
Table 1: List of modeled proteins with their PMDB ID
PMDB ID Protein name Confidence 
score (%)
PMDB ID Protein name Confidence 
score (%)
PM0082936 Putative peptide synthase 95.03 PM0082955 Phenolpthiocerol synthesis type-I 
polyketide synthase PpsC
92.31
PM0082938 Polyketide synthase Pks6 94.51 PM0082956 Phenolpthiocerol synthesis type-I 
polyketide synthase PpsC
92.31
PM0082939 PPE family protein 100 PM0082957 Phenolpthiocerol synthesis type-I 
polyketide synthase PpsC
92.31
PM0082940 Carrier domain-containing protein 93.77 PM0082958 Phenolpthiocerol synthesis type-I 
polyketide synthase PpsC
92.31
PM0082941 PPE family protein 90.62 PM0082959 Phthiocerol synthesis polyketide 
synthase type-I PpsC
92.25
PM0082942 SDR family NAD(P)-dependent 
oxidoreductase
93.24 PM0082960 Polyketide synthase 92.31
PM0082943 PPE family protein 90.62 PM0082961 Phthiocerol synthesis polyketide 
synthase type-I PpsC
92.27
PM0082944 Polyketide synthase Pks12 92.67 PM0082962 Phthiocerol synthesis polyketide 
synthase type-I PpsC
92.31
PM0082945 Polyketide synthase 91.81 PM0082963 Phenolpthiocerol synthesis type-I 
polyketide synthase PpsC
92.31
PM0082946 PPE family protein PPE5 88.52 PM0082947 Phenolpthiocerol synthesis type-I 
polyketide synthase PpsC
92.34
PM0082948 Polyketide synthase PKS 93.24 PM0082967 Type-I polyketide synthase 91.84
PM0082949 Amino acid adenylation domain-
containing protein
93.51 PM0082968 Polyketide beta-ketoacyl synthase 92.91
PM0082950 Uncharacterized protein 93.72 PM0082969 PPE family protein 100
PM0082951 Uncharacterized protein 93.95 PM0082970 Carrier domain-containing protein 93.50
PM0082952 Uncharacterized protein 93.33 PM0082971 Polyketide synthase 93.16
PM0082953 Phthiocerol/phenolphthiocerol 
polyketide synthase type-I PpsC
92.31 PM0083102 Fatty acid synthase 94.49
PM0082954 Phthiocerol synthesis polyketide 
synthase type-I PpsC
92.31 PM0083104 Probable fatty acid synthase FAS 94.11
PM0082964 Phenolphthiocerol synthesis type- PpsC 92.31 PM0083105 Type 1 polyketide synthase 91.86
PM0082965 Phenolpthiocerol synthesis type-I 
polyketide synthase PpsC
92.44 PM0083106 Fatty acid synthase 93.57
PM0082966 Polyketide synthase 92.52 PM0083107 Fatty acid synthase 91.92
PM0083113 PPE family protein 94.65 PM0083108 Probable fatty acid synthase FAS 91.92
PM0083114 Polyketide synthase PKS 89.36 PM0083133 Fatty acid synthase 92.99
PM0083115 PPE family protein 98.72 PM0083110 Type 1 polyketide synthase 97.89
PM0083116 PPE family protein 92.83 PM0083110 PPE family protein 91.76
PM0083117 Uncharacterized protein 98.31 PM0083112 PPE domain-containing protein 94.65
PM0083118 Uncharacterized protein 94.65 PM0083126 Non-ribosomal peptide synthetase 91.84
PM0083119 PPE family protein 95.02 PM0083130 Non-ribosomal peptide synthetase 98.10
PM0083120 Uncharacterized PPE family protein 
PPE54
94.65 PM0083131 amino acid adenylation domain-
containing protein
94.49
PM0083121 PPE domain-containing protein 94.64 PM0083132 amino acid adenylation domain-
containing protein
91.76
PM0083122 Peptide synthetase, putative 90.71 PM0083125 Non-ribosomal peptide synthetase 91.84
PM0083123 Peptide synthetase Nrp 91.85 PM0083134 PPE family protein 94.65
PM0083124 Probable protein synthetase nrp 94.65 PM0083127 Peptide synthetase 94.49
PM0083109 Putative FAS 96.88 PM0083128 Probable peptide synthetase Nrp 
(peptide synthase)
98.12
PM0083129 Putative peptide synthetase NRP  
(peptide synthase)
98.12
PMDB: Protein Model Database, FAS: Fatty acid synthase
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plot was used as the quantitative analysis of the reliability of the 
modeled proteins [22-24]. The result is a score of favorability called 
Ramachandran favored region. The Ramachandran favored also 
denoted in this study as confidence score for each model of each 
protein was stored. For the next procedure, the Ramachandran favored 
score was used for screening. Only those models with high confidence 
scores were taken into consideration [2].
Model submission
The 3D models thus predicted were submitted to the PMDB (http://
srv00.recas.ba.infn.it/PMDB/main.php) which is a public resource 
database aimed at storing manually built 3D protein structures. The 
database is designed to provide access to models published in the 
scientific literature together with validating experimental data [1,2].
RESULTS
Building homology model
A total of 100 different protein sequences belonging to M. tuberculosis 
were retrieved from the UniProt database. All the sequences were 
subjected for BLASTn analysis in the NCBI tools, to identify significant 
match. Among the 100 sequences, only 69 protein sequences had 
80% similarity match to the known protein structures in the PDB 
website. This suggests that significant portion of the proteins does 
not have known structures and is important to construct models of 
those proteins, for further applications. All the 100 sequences were 
analyzed to identify whether they are reported drug targets according 
to DrugBank database website. A total of 70 entries were identified as 
potential drug targets and thus playing important role in drug discovery 
and development. All the 100 sequences were subjected for homology 
model construction using the SWISS-Model online tool. The web tool 
has generated multiple models 1~5 different models for each entries. 
The best model for each protein was selected using Ramachandran plot 
analysis.
Ramachandran plot validation
Ramachandran plot analysis was employed as the quantitative 
analysis to predict the reliability of the modeled proteins, based on 
Ramachandran favored scores that are obtained by the MolProbity 
inbuilt within the SWISS-Model online tool. The predicted models were 
considered significant, only if the percentage of Ramachandran favored 
regions was above 85%. Hence, among the multiple models that were 
generated for each protein, the protein showed highest percentage 
of residues in the Ramachandran favored regions. Fig. 1 shows the 
Ramachandran plot analysis of a preferred model with >85% favored 
region and also a least preferred model with <85% Ramachandran 
favored region. A total of 69 protein models demonstrated significant 
score in Ramachandran plot and hence were selected for further 
processing.
Submission to PMDB
The 69 protein models that were selected from Ramachandran plot 
analysis were submitted to an online database, that is, PMDB (https://
bioinformatics.cineca.it/PMDB/) for public availability to access for 
research purposes. The details of the constructed models and their 
PMDB entry ID are summarized in Table 1.
CONCLUSION
This study aimed at construction of computational 3D protein 
structures of M. tuberculosis using homology modeling. From the 
initial selected 100 proteins of the organism, a total of 69 proteins 
were successfully modeled with significant confidence score based on 
Ramachandran plot analysis. These modeled 3D structures were made 
available to the public through the PMDB database for computational 
protein models. Hence, in this study, the 3D structures of potential 
drug target proteins in M. tuberculosis were predicted and submitted 
for public access. This can be significantly useful for drug discovery 
and development of targeted drugs, specific to drug resistance, and 
strain specificity. The major problem in the treatment of tuberculosis 
is the rapid development of resistance and the varying sensitivity 
among different strains of the organism. Using the similar homology 
modeling approach, the drug resistance and sensitivity issues could be 
solved. This provides advantage to the structure-based computational 
drug design studies, on M. tuberculosis organism, aiding to developing 
an effective drug variant to overcome the current challenges faced by 
health care.
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Fig. 1: Ramachandran plot analysis of modeled proteins; (a) Preferred model with minimum of >85% confidence score; (b) Rejected 
model with <85% confidence score
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